Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Tessema, Belay ^a,b   Beer, Joerg ^b   Emmrich, Frank ^b,c   Sack, Ulrich ^b,c   Rodloff, Arne C ^b  

^a UNIVERSITY OF GONDAR   (Ethiopia)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

Drug resistance; Gene mutation; Mycobacterium tuberculosis

Indexed keywords

ASPARTIC ACID; ETHAMBUTOL; HISTIDINE; ISOLEUCINE; ISONIAZID; LEUCINE; METHIONINE; RIFAMPICIN; SERINE; VALINE; BACTERIAL PROTEIN; CATALASE; DNA DIRECTED RNA POLYMERASE; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; RNA POLYMERASE BETA SUBUNIT; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; EMBB GENE; ETHIOPIA; FEMALE; GENE MUTATION; GENE PROBE; HUMAN; INHA GENE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RPOB GENE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SMEAR; THREE DIMENSIONAL IMAGING; TUBERCULOSIS; ANALYTICAL EQUIPMENT; DRUG EFFECT; EVALUATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MISSENSE MUTATION; MOLECULAR DIAGNOSIS;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; CHILD; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; ETHAMBUTOL; ETHIOPIA; FEMALE; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; YOUNG ADULT;

EID: 84856771328     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-37     Document Type: Article

References (38)

1. World Health Organization Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and esponse.WHO/HTM/TB/2010.3 2010, Geneva: WHO, World Health Organization.
2. World Health Organization Anti-tuberculosis drug resistance in the world. Fourth Global Report. WHO/HTM/TB/2008.394 2008, Geneva: WHO, World Health Organization.
3. World Health Organisation Global tuberculosis control. Surveillance, planning and financing. WHO report WHO/HTM/TB/2008.393 2008, Geneva: WHO, World Health Organisation.
4. World Health Organization Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2006.361 2006, Geneva: WHO, World Health Organization.
5. Dorman SE, Chaisson RE. From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis. Nature Med 2007, 13:295-298. 10.1038/nm0307-295, 17342143.
6. Ministry of Health of Ethiopia Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme Manual 2008, Addis Ababa: MOH, Ministry of Health of Ethiopia.
7. World Health Organisation Strategic and technical advisory group for tuberculosis (STAG-TB) report on conclusions and recommendations. Seventh meeting 2007, Geneva: WHO, World Health Organisation.
8. World Health Organization Policy Statement: Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB) 2008, Geneva: WHO, World Health Organization.
9. Ahmad S, Mokaddas E. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med 2009, 103:1777-179. 10.1016/j.rmed.2009.07.010, 19660927.
10. Ani AE. Advances in the laboratory diagnosis of Mycobacterium tuberculosi. Ann Afr Med 2008, 7:57-61. 10.4103/1596-3519.55680, 19143160.
11. Grandjean L, Moore DA. Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis 2008, 21:454-461. 10.1097/QCO.0b013e32830ce783, 2955353, 18725793.
12. Ioannidis P, Papaventsis D, Karabela S, Nikolaou S, Panagi M, Raftopoulou E, Konstantinidou E, Marinou I, Kanavaki S. Cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results. J Clin Microbiol 2011, 49:3068-3070. 10.1128/JCM.00718-11, 3147726, 21677069.
13. Vilcheze C, Jacobs WR. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu Rev Microbiol 2007, 61:35-50. 10.1146/annurev.micro.61.111606.122346, 18035606.
14. Cole ST. Rifamycin resistance in mycobacteria. Res Microbiol 1996, 147:48-52. 10.1016/0923-2508(96)80203-8, 8761722.
15. Riccardi G, Pasca MR, Buroni S. Mycobacterium tuberculosis:drug resistance and future perspectives. Future Microbiol 2009, 4:597-614. 10.2217/fmb.09.20, 19492969.
16. Malik AN, Godfrey-Faussett P. Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. Lancet Infect Dis 2005, 5:174-183.
17. Nicol MP, Wilkinson RJ. The clinical consequences of strain diversity in Mycobacterium tuberculosis. Tran R Soc Trop Med Hyg 2008, 102:955-965.
18. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008, 177:787-792. 10.1164/rccm.200709-1436OC, 18202343.
19. Brossier F, Veziris N, Tuffot-Pernot C, Jarlier V, Sougakoff W. Performance of the Genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin Microbiol 2006, 44:3659-3664. 10.1128/JCM.01054-06, 1594786, 17021094.
20. Evans J, Stead MC, Nicol MP, Segal H. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. J Antimicrob Chemother 2009, 63:11-16.
21. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005, 43:3699-3703. 10.1128/JCM.43.8.3699-3703.2005, 1233903, 16081898.
22. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008, 32:1165-1174. 10.1183/09031936.00061808, 18614561.
23. Makinen J, Marttila HJ, Marjamaki M, Viljanen MK, Soini H. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006, 44:350-352. 10.1128/JCM.44.2.350-352.2006, 1392655, 16455882.
24. Miotto P, Piana F, Penati V, Caducci F, Migloiori GB, Cirillo DM. Use of Genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 2006, 44:2485-2491. 10.1128/JCM.00083-06, 1489497, 16825369.
25. Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC. Rate of recovery of Mycobacterium tuberculosis from frozen acid-fast-bacillus smear-positive sputum samples subjected to long term storage in Northwest Ethiopia. J Clin Microbio 2011, 49:2557-2561.
26. Beer J, Küchler R, Rodloff AC. Investigations about the possibility for testing the susceptibility of mycobacteria with the MB/BacT culture system. J Lab Med 1997, 21:390-398.
27. Tortoli E, Mattei R, Savarino A, Bartolini L, Beer J. Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460 TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems. Diagnostic Microbio Infec Dis 2000, 38:83-86.
28. Causse M, Ruiz P, Gutierrez JB, Zerolo J, Casal M. Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2008, 12:1456-1460.
29. Bwanga F, Hoffner S, Haile M, Joloba ML. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009, 9:67. 10.1186/1471-2334-9-67, 2696456, 19457256.
30. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, Melentyev A, Fedorin I. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 2005, 293:2726-2731. 10.1001/jama.293.22.2726, 15941801.
31. Lipin MY, Stepanshina VN, Shemyakin IG, Shinnick TM. Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. Clin Microbiol Infect 2007, 13:620-626. 10.1111/j.1469-0691.2007.01711.x, 17403134.
32. Hazbon MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, León CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de León A, Alland D. Population genetics study of isoniazid resistance mutations and evolution of multidrug- resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006, 50:2640-2649. 10.1128/AAC.00112-06, 1538650, 16870753.
33. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosi. Int J Tuberc Lung Dis 2009, 13:1320-1330.
34. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, Matter L, Schopfer K, Bodmer T. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993, 341:647-650. 10.1016/0140-6736(93)90417-F, 8095569.
35. Zhang L, Ye Y, Duo L, Wang T, Song X, Lu X, Ying B, Wang L. Application of Genotype MTBDRplus in rapid detection the Mycobacterium tuberculosi complex as well as its resistance to isoniazid and rifampin in a high volume laboratory in Southern China. Mol Biol Rep 2011, 38:2185-2192. 10.1007/s11033-010-0347-0, 20852939.
36. Huang WL, Chi TL, Wu MH, Jou R. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2011, 49:2502-2508. 10.1128/JCM.00197-11, 3147822, 21562102.
37. Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs. Int J Tuberc Lung Dis 2012, 16:104-109. 10.5588/ijtld.10.0600, 22236854.
38. Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2010, 48:1683-1689. 10.1128/JCM.01947-09, 2863904, 20335420.